Keefe Bruyette lowered the firm’s price target on Ryan Specialty (RYAN) to $76 from $77 and keeps an Outperform rating on the shares. Ryan’s Q4 EPS was in line with Street estimates, though 2025 margin guidance is a little “light,” the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Buy Recommendation for Ryan Specialty Group Amid Strong Financial Performance and Growth Prospects
- Strong Financial Performance and Strategic Investments Propel Ryan Specialty Group to ‘Buy’ Rating
- Ryan Specialty Reports Strong Q4 2024 Growth
- Ryan Specialty reports Q4 adjusted EPS 45c, consensus 45c
- Ryan Specialty sees FY25 revenue growth 11%-13%